Table 2.

Validation of Mycological Tests in Multi-Center Studies of CAPA Patients [22,23,24].

Diagnostic Test	Sensitivity	Specificity
GM in BAL > 1	74% (77/104)	99% (268/272)
BAL culture	53% (56/106)	100% (298/298)
Lateral flow BAL	52% (15/29)	98% (60/61)
BAL PCR	42% (48/115)	100% (49/49)
Serum GM > 0.5	19% (20/106)	100% (379/380)
1-3-β-D-glucan	38% (8/21)	85% (29/34)

BAL, bronchoalveolar lavage; GM, galactomannan.